Variant report
Variant | esv3342257 |
---|---|
Chromosome Location | chr2:50564138-50564575 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545285302 | chr2:50564193-50564194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141766385 | chr2:50564201-50564202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552584189 | chr2:50564216-50564217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368230571 | chr2:50564221-50564222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374223084 | chr2:50564222-50564223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185944100 | chr2:50564243-50564244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145510051 | chr2:50564244-50564245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145408902 | chr2:50564257-50564258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531421784 | chr2:50564275-50564276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560791819 | chr2:50564293-50564294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549641385 | chr2:50564328-50564329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564894908 | chr2:50564375-50564376 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113714188 | chr2:50564408-50564409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113271970 | chr2:50564443-50564444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191056187 | chr2:50564450-50564451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112345315 | chr2:50564451-50564452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12466945 | chr2:50564465-50564466 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs569779136 | chr2:50564466-50564467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538333876 | chr2:50564469-50564470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556419802 | chr2:50564470-50564471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140769902 | chr2:50564502-50564503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538599438 | chr2:50564508-50564509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553769737 | chr2:50564513-50564514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572371576 | chr2:50564515-50564516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542949993 | chr2:50564538-50564539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs28581739 | chr2:50564543-50564544 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs116619057 | chr2:50564549-50564550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50548400-50570600 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr2:50560800-50569600 | Weak transcription | Fetal Brain Female | brain |
3 | chr2:50562600-50570800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:50562800-50565200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr2:50563000-50564200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr2:50563000-50564200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:50563400-50571200 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr2:50563600-50566000 | Enhancers | Brain Germinal Matrix | brain |
9 | chr2:50563800-50564400 | Enhancers | Fetal Brain Male | brain |
10 | chr2:50563800-50567400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:50564000-50567600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr2:50564000-50569400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
13 | chr2:50564000-50571000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
14 | chr2:50564200-50571400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
15 | chr2:50564400-50565200 | Weak transcription | Fetal Brain Male | brain |